WallStreetZenWallStreetZen

NASDAQ: IMNM
Immunome Inc Stock Ownership - Who owns Immunome?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immunome Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jean Jacques BienaimeDirector2025-06-035,000$9.38
$46.90kBuy
Jack HigginsChief Scientific Officer2025-03-275,200$1.35
$7.02kBuy
Clay B. SiegallPresident and CEO2025-03-26137,100$7.29
$999.46kBuy
Jean Jacques BienaimeDirector2025-03-257,800$7.78
$60.68kBuy
Philip TsaiChief Technology Officer2025-03-2412,300$8.42
$103.57kBuy
Jean Jacques BienaimeDirector2025-03-247,000$8.21
$57.47kBuy
Clay B. SiegallPresident and CEO2025-01-31150,000$7.75
$1.16MBuy
Clay B. SiegallPresident and CEO2024-11-2233,943$9.78
$331.93kBuy
Clay B. SiegallPresident and CEO2024-11-2166,057$9.54
$630.25kBuy
Philip TsaiChief Technology Officer2024-11-2121,000$9.43
$198.03kBuy

1 of 2

IMNM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMNM insiders and whales buy or sell their stock.

IMNM Shareholders

What type of owners hold Immunome Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc8.68%7,554,594$78.95MInstitution
Blackrock Inc6.51%5,662,699$59.18MInstitution
Redmile Group LLC6.16%5,361,187$56.02MInstitution
Enavate Sciences GP LLC5.48%4,768,583$49.83MInstitution
Point72 Asset Management LP5.01%4,360,675$45.57MInstitution
Vanguard Group Inc4.95%4,307,191$45.01MInstitution
Ecor1 Capital LLC4.69%4,079,415$42.63MInstitution
Fmr LLC4.47%3,892,318$40.67MInstitution
Opaleye Management Inc4.08%3,550,000$37.10MInstitution
Primecap Management Co3.92%3,413,700$35.67MInstitution

1 of 3

IMNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMNM88.41%7.69%Net BuyingNet Buying
PROK16.40%40.52%Net BuyingNet Buying
MLYS61.27%38.73%Net BuyingNet Selling
REPL66.30%33.70%Net SellingNet Selling
AVXL36.80%5.15%Net BuyingNet Buying
View Top Biotech Stocks

Immunome Stock Ownership FAQ

Who owns Immunome?

Immunome (NASDAQ: IMNM) is owned by 88.41% institutional shareholders, 7.69% Immunome insiders, and 3.90% retail investors. Isaac Barchas is the largest individual Immunome shareholder, owning 2.83M shares representing 3.26% of the company. Isaac Barchas's Immunome shares are currently valued at $29.98M.

If you're new to stock investing, here's how to buy Immunome stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.